CompoAtlas

EPA-625

Retirée du marché américain le 22 December 2022 (selon le DSLD)

Cardiovascular Research, food supplement from the US market

Label withdrawn from the US market. EPA-625 (Cardiovascular Research), a food supplement au code-barres 696859131820, is described by its US market label. The French and European rules we can apply to this label flag no particular point. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

If this product were sold in France

No point flagged by the rules we apply.

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Cardiovascular Research
Barcode
696859131820
Form
Softgel
One serving
1 softgel
Servings
up to 1 serving per day
Other ingredients (in English, as written)
Gelatin, Glycerin, Mixed Natural Tocopherols, Gelatin, Glycerin, Water, Purified
Ingredient (as written, in English)CategoryPer serving
CaloriesOther15 Calorie(s)
Calories from FatOther10 Calorie(s)
Total FatFat1.5 Gram(s)
Saturated FatFat0 Gram(s)
Polyunsaturated FatFat1.5 Gram(s)
Monounsaturated FatFat0 Gram(s)
CholesterolFatnot stated
Fish OilFat1,360 mg
Eicosapentaenoic AcidFatty acid625 mg
Docosahexaenoic AcidFatty acid245 mg
Other Omega-3 Fatty AcidsFatty acid82 mg
Total Omega-3 Fatty AcidsFatty acid952 mg

Other versions of this label

The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Fish Oil
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Cardiovascular Research

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line